# Laborie Medical Technologies

> Laborie Medical Technologies is a VC fund backing Health Care and Medical. See 8 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Mississauga, Canada
- Total investments: 8
- Last investment: Oct 2024
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/laborie
- X (Twitter): https://www.twitter.com/laboriemedical
- Website: http://laborie.com/
- Facebook: http://www.facebook.com/pages/Laborie-Medical/123404141047093

Laborie Medical Technologies is a global developer, manufacturer and marketer of innovative medical technology and consumables used for the diagnosis and treatment of Urinary and Fecal Incontinence, as well as other pelvic floor disorders in the Urology, Gynecology, and Colorectal fields. Laborie is owned by Audax Group Private Equity based inBoston, MA.

## Contacts

5 contacts available for Laborie Medical Technologies. Shizune tracks 8 team members at Laborie Medical Technologies. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/laborie-medical-technologies?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $26M–$32M |
| Venture - Series Unknown | $11M–$16M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 63% |
| Medical | 4 | 50% |
| Medical Device | 4 | 50% |
| Fitness | 1 | 13% |
| Therapeutics | 1 | 13% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 25% |
| Venture - Series Unknown | 2 | 25% |
| Funding Round | 1 | 13% |
| Corporate Round | 1 | 13% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 4 | 50% |
| Israel | 2 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bo Jesper Hansen | Chairman of the Board | 0 | https://shizune.co/investors/profile/bo-jesper-hansen |
| Gail Ciccione | Chief Operating Officer | 0 | https://shizune.co/investors/profile/gail-ciccione-6c5b |
| Ray Laborie | Founder | 0 | https://shizune.co/investors/profile/ray-laborie-f8b5 |
| Daniel Merz | Chief Technology Officer | 0 | https://shizune.co/investors/profile/daniel-merz-1b11 |
| Nikki Bruce | Vice President and General Manager | 0 | https://shizune.co/investors/profile/nikki-bruce-d1fa |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Bright Uro | Bright Uro is an early-stage medical technology company. It is building the next generation of diagnostic devices for Urology. Utilizing advanced hardware, software, and data science can unlock new data streams and offer actionable insight for clinicians. | $32M | Series A | Oct 31, 2024 |  |
| Vensica Medical | Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates. | $11M | Venture - Series Unknown | Oct 28, 2024 |  |
| Novocuff | Novocuff is a medical device firm that aims to improve pregnancy outcomes and reduce preterm deliveries caused by PPROM and cervical shortening. | $26M | Series A | Jul 17, 2024 |  |
| I-O Urology | I-O Urology provides a patient monitoring system for urology. | $16M | Venture - Series Unknown | Jan 02, 2024 |  |
| Bright Uro | Bright Uro is an early-stage medical technology company. It is building the next generation of diagnostic devices for Urology. Utilizing advanced hardware, software, and data science can unlock new data streams and offer actionable insight for clinicians. | $31M | Series A | Nov 30, 2023 |  |
| GIE Medical | GIE Medical is a medical organization that specializes in fitness care, scientific device, fitness diagnostics. | $5M | Corporate Round | Sep 06, 2023 |  |
| Vensica Medical | Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates. | $16M | Venture - Series Unknown | Nov 01, 2021 |  |
| iTind | iTind is an Israeli medical device company. Our company is dedicated to improving men’s healthcare and quality of life via effective, non-surgical solutions for Benign Prostatic Hyperplasia (BPH). The flagship iTind treatment for BPH currently has the EU CE Mark and is approved for sale in the European Union, UK, Israel, Australia, Brazil, and FDAcleared for use in the USA. |  |  | Jul 07, 2016 |  |

8 of 8 investments shown.

## Co-investors
- [AXA Investment Managers](https://shizune.co/investors/profile/axa-investment-managers) — VC Fund, 2 deals together
- [Israel Biotech Fund](https://shizune.co/investors/profile/israel-biotechfund) — VC Fund, 2 deals together
- [Agriline](https://shizune.co/investors/profile/agriline) — VC Fund, 1 deal together
- [Avestria Ventures](https://shizune.co/investors/profile/avestria-ventures) — VC Fund, 1 deal together
- [Alderline Group](https://shizune.co/investors/profile/freepoint-capital-group) — VC Fund, 1 deal together
- [Laerdal Million Lives Fund](https://shizune.co/investors/profile/laerdal-million-lives-fund) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Middle East](https://shizune.co/investors/medical-device-investors-middle-east)
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)
- [Medical Device Investors in Israel](https://shizune.co/investors/medical-device-investors-israel)
- [Medical Device VC Funds in Israel](https://shizune.co/investors/medical-device-vc-funds-israel)

## FAQ

### What does Laborie Medical Technologies invest in?

Laborie Medical Technologies invests primarily in Health Care, Medical and Medical Device startups, most often at Series A and Venture - Series Unknown stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Laborie Medical Technologies's check size?

Laborie Medical Technologies typically joins rounds of $26M–$32M at Series A and $11M–$16M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Laborie Medical Technologies participates in.

### How do I contact Laborie Medical Technologies?

Public channels for Laborie Medical Technologies include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Laborie Medical Technologies?

The team at Laborie Medical Technologies includes Bo Jesper Hansen (Chairman of the Board), Gail Ciccione (Chief Operating Officer) and Ray Laborie (Founder), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co